Biblio Discovery — Demo Discovery Service

25 hasil

Menampilkan 1–20 · 0,83 detik · RSS

Jurnal

Frontiers in Lupus

ISSN 2813-6934 · Frontiers Media S.A. · 25 artikel di indeks

  1. Artikel Jurnal

    The urgent need for randomized controlled trials in pregnant women with antiphospholipid antibodies—protecting women through research

    Christine Graversgaard Adams; Jullie Rudnicki; Berit Fabricius Petersen dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionObstetric antiphospholipid syndrome (OAPS) is an autoimmune disorder associated with pregnancy morbidity, including recurrent pregnancy loss, preeclampsia and fetal growth restriction. Despite standard of care (SoC) with low-dose aspirin (LDA) and low-molecular-weight heparin (LMWH)…

  2. Artikel Jurnal

    Evaluation of the Mainz Lupus Score: a clinical support tool for managing Systemic Lupus Erythematosus

    Matthias Dreher; Jessica Amon; Simone Cosima Boedecker-Lips dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionSystemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by multi-organ involvement, circulating autoantibodies, and relapsing-remitting progression. Effective management is particularly challenging for less-experienced clinicians. The Mainz Lupus Score…

  3. Artikel Jurnal

    Targeted therapies in systemic lupus erythematosus: mechanistic insights and clinical evidence from phase II and III trials

    João Francisco Abrantes; Marina Dueñas-Ochoa; Roni Meidan dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionSystemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease characterised by autoantibody production and dysregulated B- and T- cell activation, resulting in multisystem involvement. Despite therapeutic advances, persistently active and corticosteroid-dependent disease…

  4. Artikel Jurnal

    Adverse pregnancy outcome associations among women prior to a diagnosis of systemic lupus erythematosus

    Jessica A. English; Bethany J. Wolf; Diane L. Kamen

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundImmune dysregulation years prior to a clinical diagnosis of systemic lupus erythematosus (SLE) may include a range of asymptomatic autoantibody positivity to clinically evident disease. The effect of this spectrum of immune dysregulation on pregnancy outcomes, including pregnancies in…

  5. Artikel Jurnal

    Oral contraceptive pill Use is associated with lower levels of plasma calprotectin in premenopausal women

    Daniele Marcy; Caroline Maretz; Kristin Sturm dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionNeutrophil extracellular traps (NETs) are increasingly recognized as having important roles in autoimmune disease pathogenesis. In many autoimmune diseases, e.g., rheumatoid arthritis (RA) and lupus (SLE), premenopausal women have increased incidence. Understanding immunologic effects…

  6. Artikel Jurnal

    Unsupervised machine-learning algorithm identifies clinically distinct phenotypes across patients initiating belimumab in the Lupus Italian REgistry (LIRE)

    Mariele Gatto; Vincenzo Venerito; Davide Rozza dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundBelimumab is used as add-on therapy in patients with refractory systemic lupus erythematosus (SLE). While shared features guide patient eligibility, whether clinical and laboratory variables may identify distinct candidate subgroups remain unclear.AimTo identify clinical clusters among…

  7. Artikel Jurnal

    Assessment of ovarian reserve in reproductive age Indian women with lupus and determination of correlates of diminished reserve: results from a tertiary care centre

    Siddharth Jain; Aasheesh Kumar; Uma Shankar Verma dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundFertility remains a controversial issue in women with systemic lupus erythematosus (SLE); it is largely preserved, though a subset experiences subfertility due to multiple interacting factors. Small studies on anti-mullerian hormone (AMH) as an ovarian reserve marker in SLE have yielded…

  8. Artikel Jurnal

    The brain in antiphospholipid syndrome beyond thrombosis

    Yuichiro Fujieda

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    Ischemic stroke is the most readily recognized neurological feature of antiphospholipid syndrome (APS), particularly in young patients and in cryptogenic stroke. Cognitive dysfunction, chorea, headache, and seizures are also well described in the literature. These manifestations are often not…

  9. Artikel Jurnal

    Serum autoantibody profiling in systemic lupus erythematosus reveals associations with low disease activity and remission

    Laura E. Eades; William A. Figgett; Katie Lennard dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    BackgroundKnowledge of autoantibody specificities and their clinical associations in systemic lupus erythematosus (SLE) is largely limited to panels testing a finite number of autoantibodies. We aimed to explore high-plex serum autoantibody profiles in SLE and examine associations with…

  10. Artikel Jurnal

    Cardiovascular risk in systemic lupus erythematosus: beyond Framingham to emerging risk prediction tools and therapeutic approaches

    Mona Aflaki; Joanne M. Bargman

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune dysregulation and persistent inflammation. Although the prognosis of patients with SLE has improved substantially over the past few decades, these patients remain at markedly increased risk of cardiovascular…

  11. Artikel Jurnal

    Baseline factors defining immune complex detection in systemic lupus erythematosus: development of a three-factor score in a retrospective cohort study

    Hiroshi Oiwa; Akihiro Yahata; Naoki Nakamoto

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    ObjectiveImmune complexes (ICs) play a central role in the pathogenesis of systemic lupus erythematosus (SLE). We previously showed that detectable ICs predicted clinical remission off corticosteroids (CR off C), also referred to as glucocorticoid-free clinical remission. Because the C1q-based IC…

  12. Artikel Jurnal

    Positioning rituximab in the therapeutic strategies for SLE

    Chrysanthi Staveri; Stamatis-Nick C. Liossis

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    Systemic lupus erythematosus (SLE) is one of the most challenging diseases to manage due to its high heterogeneity and unpredictable course. Rituximab is an off-label, widely administered treatment in severe, refractory SLE. Observational and real-world evidence studies have been highly…

  13. Artikel Jurnal

    Safety and efficacy of novel therapeutics in lupus: a narrative review

    Michael F. Loncharich; Brenna E. Cafeo; Evan B. Noble

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    Systemic lupus erythematosus (SLE) poses diagnostic and management challenges to physicians given its protean manifestations and complex immune dysregulation. Numerous drugs are used in the management of lupus with a plethora under investigation for more effective, safe, and targeted therapies…

  14. Artikel Jurnal

    Evaluating the efficacy of SK1217 in attenuating pristane-induced lupus in mice

    Swetha Kakkerla; Sridhar Kavela; Sathvika Chintalapani

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    IntroductionSystemic lupus erythematosus (SLE) is a multifactorial autoimmune disorder characterized by aberrant immune activation, autoantibody production, immune complex deposition, and progressive organ damage, particularly lupus nephritis. Developing therapies that can simultaneously modulate…

  15. Artikel Jurnal

    Postpartum challenges in women with systemic autoimmune diseases

    Dina Zucchi; Chiara Tani; Giancarlo Cascarano dkk.

    Frontiers in Lupus, Vol. 4 · 2026 · Inggris · DOAJ

    The postpartum period represents a critical and underexplored phase in the reproductive course of women with systemic autoimmune diseases (SAD). While advances in disease management have substantially improved pregnancy outcomes, the weeks and months after delivery remain associated with a…

  16. Artikel Jurnal

    Case Report: Biologic-free clinical remission following anifrolumab discontinuation in systemic lupus erythematosus—two-case reports

    Takako Hashimoto; Hidekata Yasuoka

    Frontiers in Lupus, Vol. 3 · 2026 · Inggris · DOAJ

    BackgroundAnifrolumab, a monoclonal antibody against the type I interferon receptor, has shown efficacy in systemic lupus erythematosus (SLE). However, sustained remission after drug discontinuation has been rarely reported.Case presentationWe reported two females with SLE who achieved…

  17. Artikel Jurnal

    Sjögren's disease and systemic lupus erythematosus overlap: immunological insights and therapeutic implications

    Giovanni Fulvio; Gaetano La Rocca; Chiara Tani dkk.

    Frontiers in Lupus, Vol. 3 · 2025 · Inggris · DOAJ

    Sjögren's disease (SjD) and systemic lupus erythematosus (SLE) are distinct autoimmune disorders and their clinical overlap presents a unique immunological entity with specific challenges. While the clinical manifestations of the SjD-SLE overlap have been extensively characterised, its underlying…

  18. Artikel Jurnal

    Evaluating CXCR6 and its ligand CXCL16 as biomarkers for lupus organ involvement: a mini review and brief research report

    Faradia Kernizan; Himanee Dave; Victoria Rossetti dkk.

    Frontiers in Lupus, Vol. 3 · 2025 · Inggris · DOAJ

    Cutaneous lupus erythematosus (CLE) is a group of skin disorders where the immune system attacks skin cells. CLE can affect people who have systemic lupus erythematosus, or can occur independently. In prior studies, CXCL16 and its primary receptor, CXCR6, have been shown to be elevated at the RNA…